Five Prime Therapeutics (FPRX) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Join SI Premium – FREE
Five Prime Therapeutics (NASDAQ: FPRX) reported Q1 EPS of ($0.63), $0.08 worse than the analyst estimate of ($0.55).
For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
